[1]王照昱,刘 超.黄芪丹参汤对脑梗死恢复期患者认知功能的影响[J].医学信息,2022,35(21):143-146.[doi:10.3969/j.issn.1006-1959.2022.21.038]
　WANG Zhao-yu,LIU Chao.Effect of Huangqi Danshen Decoction on Cognitive Function in Patients with Cerebral Infarction in Recovery Period[J].Journal of Medical Information,2022,35(21):143-146.[doi:10.3969/j.issn.1006-1959.2022.21.038]
点击复制

黄芪丹参汤对脑梗死恢复期患者认知功能的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年21期
页码:
143-146
栏目:
中医中药
出版日期:
2022-11-01

文章信息/Info

Title:
Effect of Huangqi Danshen Decoction on Cognitive Function in Patients with Cerebral Infarction in Recovery Period
文章编号:
1006-1959（2022）21-0143-04
作者:
王照昱; 刘 超
（西安市高陵区中医医院脑病科1，心血管内科2，陕西 西安 712000）
Author(s):
WANG Zhao-yu; LIU Chao
(Department of Encephalopathy1,Department of Cardiology2,Gaoling District Hospital of Traditional Chinese Medicine,Xi’an 712000,Shaanxi,China)
关键词:
脑梗死; 黄芪丹参汤; 认知功能; 神经功能; 生活质量
Keywords:
Cerebral infarction; Huangqi Danshen decoction; Cognitive function; Neurological function; Quality of life
分类号:
R743.3
DOI:
10.3969/j.issn.1006-1959.2022.21.038
文献标志码:
A
摘要:
目的 研究黄芪丹参汤对脑梗死恢复期患者认知功能的影响。方法 选取2019年7月-2021年7月我院收治的68例脑梗死恢复期患者作为研究对象，采用随机数字表法分为对照组与观察组，各34例。对照组行常规西医治疗，观察组在对照组基础上联合黄芪丹参汤治疗，比较两组中医症候积分、神经功能[美国国立卫生研究院卒中量表（NIHSS）、神经功缺损程度评分（CNDS）]、认知功能[蒙特利尔认知评估量表（MoCA）、Rivermead行为记忆量表（RBMT）]、肢体运动功能（Fugl-Meyer运动功能评估量表、Berg量表）、生活自理能力[日常生活活动评分（ADL）]、生活质量[脑卒中专用生活质量量表（SS-QOL）评分]。结果 治疗后，观察组中医症候积分（口舌歪斜、语言障碍、肢体麻木、头痛如刺）低于对照组（P＜0.05）。观察组NIHSS、CNDS评分低于对照组，MoCA、RBMT、Fugl-Meyer、Berg、ADL、SS-QOL评分高于对照组（P＜0.05）。结论 黄芪丹参汤可有效缓解脑梗死恢复期患者的临床症状，促使神经功能恢复，提升其认知及肢体运动功能，有利于自理能力及生活质量的改善。
Abstract:
Objective To study the effect of Huangqi Danshen decoction on the cognitive function of patients with cerebral infarction in recovery period.Methods A total of 68 patients with convalescent cerebral infarction admitted to our hospital from July 2019 to July 2021 were selected as the study subjects. They were divided into control group and observation group by random number table method, with 34 cases in each group. The control group was treated with conventional western medicine, and the observation group was treated with Huangqi Danshen decoction on the basis of it. The scores of TCM syndrome and neurological function [National Institutes of Health Stroke Scale (NIHSS), Clinical Neurological Deficit Scale (CNDS)] , Cognitive function [Montreal Cognitive Assessment Scale (MoCA), Rivermead Behavioral Memory Scale (RBMT)], limb motor function (Fugl-Meyer Motor Function Assessment Scale, Berg Scale), self-care ability [Activities of Daily Life Score (ADL) score], quality of life [Stroke-specific quality of life scale (SS-QOL) score] were compared between the two groups.Results After treatment, the scores of TCM syndromes in the observation group (skewed tongue, speech disorder, numbness of the limbs, headache and thorns) were lower than those in the control group (P<0.05). The scores of NIHSS and CNDS in the observation group were lower than those in the control group, and the scores of MoCA, RBMT, Fugl-Meyer, Berg, ADL and SS-QOL were higher than those in the control group (P<0.05).Conclusion Huangqi Danshen decoction can effectively relieve the clinical symptoms of patients with cerebral infarction in the recovery period, promote the recovery of nerve function, enhance their cognition and limb motor function, and help improve their self-care ability and quality of life.

参考文献/References:

[1]Zhou D,Xie L,Wang Y,et al.Clinical Efficacy of Tonic Traditional Chinese Medicine Injection on Acute Cerebral Infarction: A Bayesian Network Meta-Analysis[J].Evidence-based Complementary and Alternative Medicine,2020,2020(7):1-12.[2]胡仕强.丹红活血汤联合西药治疗急性脑梗死恢复期48例[J].中医研究,2018,31(2):22-24.[3]冯容,张欣,陈永斌.龙蛭汤对气虚血瘀证急性脑梗死患者的临床疗效及作用机制研究[J].中国中西医结合急救杂志,2016,23(3):225-227.[4]Heiss WD,Kessler J,Karbe H,et al.Cerebral glucose metabolism as a predictor of recovery from aphasia in ischemic stroke[J].Arch Neurol,1993,50(9):958-964.[5]崔格,谭支文.自拟益智通窍汤对大面积脑梗塞后认知功能障碍患者神经功能、认知功能及生活自理能力的影响观察[J].四川中医,2021,39(10):132-135.[6]高长玉,吴成翰,赵建国,等.中国脑梗死中西医结合诊治指南(2017)[J].中国中西医结合杂志,2018,38(2):136-144.[7]姜淼,张凤杰,佐炳会,等.黄芪桂枝五物汤辅助治疗对脑梗死恢复期患者的影响[J].世界中医药,2017,12(7):1555-1558.[8]耿银龙.黄芪补血汤联合丹参川芎嗪注射液治疗老年H型高血压合并急性脑梗死患者疗效观察[J].实用临床医药杂志,2020,24(15):28-31.[9]聂圣娜,高文学,韩亚辉.黄芪桂枝五物汤联合针灸对脑梗死后遗症期患者血液流变、神经功能的影响[J].中医药临床杂志,2021,33(4):726-729.[10]刘强,代金玉.不同黄芪剂量补阳还五汤对气虚血瘀型急性脑梗死患者神经功能、运动功能的影响[J].现代中西医结合杂志,2019,28(36):4055-4058.[11]杜韬,张威.黄芪通络汤联合眼针治疗气虚血瘀证脑梗死恢复期患者临床观察[J].辽宁中医药大学学报,2020,22(2):84-87.[12]牛永义.黄芪桂枝五物汤联合养血清脑颗粒治疗脑梗死恢复期临床观察[J].光明中医,2019,34(18):2815-2817.[13]吴伟.疏血通注射液联合黄芪注射液治疗脑梗死的效果观察[J].临床合理用药杂志,2021,14(20):55-57.[14]张耀升,曹子成,马云枝.益气活血汤联合西药对急性脑梗死患者神经功能及血流动力学的影响[J].中医研究,2019,32(03):45-47.[15]林子霖.基于近15年文献分析探讨急性脑梗死的中医证治[D].广州:广州中医药大学,2014.[16]张淼,李丹丹,马民,等.基于网络药理学探讨丹参-黄芪-川芎配伍治疗冠心病心绞痛的作用机制[J].中西医结合心脑血管病杂志,2021,19(21):3640-3644.[17]牛克静.黄芪丹参汤加减治疗脑梗死52例临床分析[J].山西医药杂志,2012,41(1):68-69. [18]Pu X,Ma X,Lu L,et al.Structural characterization and antioxidant activity in vitro of polysaccharides from angelica and astragalus[J].Carbohydrate Polymers,2016,137:154-164.[19]贺小霞,郭林.黄芪丹参汤辅治脑梗死恢复期临床观察[J].实用中医药杂志,2021,37(10):1743-1745.[20]郑发.黄芪丹参汤治疗脑梗死恢复期患者的效果[J].中外医学研究,2021,19(31):18-21.[21]贾亚军,付存穰.黄芪参归汤对脑梗死患者脑神经功能的保护作用分析[J].光明中医,2017,32(2):231-233.[22]满运军,李利荣.黄芪丹参汤治疗脑梗死恢复期的疗效及对血清MMP-9、hs-CRP水平的影响[J].内蒙古中医药,2021,40(10):10-11.[23]周玉萍,王晓旭,田裕豪,等.试论脑为元神之府及临床意义[J].中华中医药杂志,2021,36(1):155-157.[24]Zhou L,Liu Z,Wang Z,et al.Astragalus polysaccharides exerts immunomodulatory effects via TLR4-mediated MyD88-dependent signaling pathway in vitro and in vivo[J].Scientific Reports,2017,7:44822.[25]Wang Y,Shi Y,Zou J,et al.The intranasal administration of Carthamus tinctorius L.extract/phospholipid complex in the treatment of cerebral infarction via the TNF-α/MAPK pathway[J].Biomedicine & Pharmacotherapy,2020,130:110563.

相似文献/References:

[1]刘海威.延续性护理对脑梗死运动功能障碍患者生活质量及社会支持的影响[J].医学信息,2018,31(02):160.[doi:10.3969/j.issn.1006-1959.2018.02.062]
　LIU Hai-wei.Effect of Continuous Nursing on Quality of Life and Social Support in Patients with Motor Dysfunction of Cerebral Infarction[J].Journal of Medical Information,2018,31(21):160.[doi:10.3969/j.issn.1006-1959.2018.02.062]
[2]韩艳庆,董 成,徐 玲.脑梗死并发急腹症诊治分析[J].医学信息,2018,31(06):188.[doi:10.3969/j.issn.1006-1959.2018.06.068]
　HAN Yan-qing,DONG Cheng,XU Ling.Analysis of Diagnosis and Treatment of Acute Cerebral Infarction Complicating Acute Abdominal Disease[J].Journal of Medical Information,2018,31(21):188.[doi:10.3969/j.issn.1006-1959.2018.06.068]
[3]王明远,陈海燕,张延朋,等.颈动脉斑块、血同型半胱氨酸及血尿酸对短暂性脑缺血 发作进程的影响研究[J].医学信息,2018,31(08):65.[doi:10.3969/j.issn.1006-1959.2018.08.020]
　WANG Ming-yuan,CHEN Hai-yan,ZHANG Yan-peng,et al.Effects of Carotid Plaque,Homocysteine and Serum Uric Acid on Transient Ischemic Attack[J].Journal of Medical Information,2018,31(21):65.[doi:10.3969/j.issn.1006-1959.2018.08.020]
[4]甘雪梅.系统护理对脑梗死患者生活质量及满意度的影响[J].医学信息,2018,31(08):172.[doi:10.3969/j.issn.1006-1959.2018.08.062]
　GAN Xue-mei.Effect of Systematic Nursing on Quality of Life and Satisfaction of Patients with Cerebral Infarction[J].Journal of Medical Information,2018,31(21):172.[doi:10.3969/j.issn.1006-1959.2018.08.062]
[5]单 敏,常燕燕,赵大鹏,等.急性前循环脑梗死患者梗死体积与 血清NSE水平相关性研究[J].医学信息,2018,31(10):1.[doi:10.3969/j.issn.1006-1959.2018.10.001]
　SHAN Min,CHANG Yan-yan,ZHAO Da-peng,et al.Correlation between Infarct Volume and Serum NSE Level in Patients with Acute Anterior Circulation Cerebral Infarction[J].Journal of Medical Information,2018,31(21):1.[doi:10.3969/j.issn.1006-1959.2018.10.001]
[6]陈艳男,徐 劲.脑梗死患者血清SAA、hs-CRP与颅内动脉粥样硬化狭窄程度的相关性[J].医学信息,2022,35(09):120.[doi:10.3969/j.issn.1006-1959.2022.09.030]
　CHEN Yan-nan,XU Jin.Correlation Between Serum SAA, hs-CRP and Intracranial Atherosclerotic Stenosis in Patients with Cerebral Infarction[J].Journal of Medical Information,2022,35(21):120.[doi:10.3969/j.issn.1006-1959.2022.09.030]
[7]李福滔,张素平.单侧颈内动脉夹层致脑梗死1例报道[J].医学信息,2018,31(11):191.[doi:10.3969/j.issn.1006-1959.2018.11.065]
[8]张怀祥,段晓宇.脑梗死后认知障碍的病理学机制、相关危险因素及治疗[J].医学信息,2018,31(16):21.[doi:10.3969/j.issn.1006-1959.2018.16.007]
　ZHANG Huai-xiang,DUAN Xiao-yu.Pathological Mechanism,Related Risk Factors and Treatment of Cognitive Impairment after Cerebral Infarction[J].Journal of Medical Information,2018,31(21):21.[doi:10.3969/j.issn.1006-1959.2018.16.007]
[9]柳 星,卢会琴.脑梗死恢复期的临床路径实施效果分析[J].医学信息,2018,31(19):128.[doi:10.3969/j.issn.1006-1959.2018.19.038]
　LIU Xing,LU Hui-qin.Analysis of Clinical Path Implementation in the Recovery Period of Cerebral Infarction[J].Journal of Medical Information,2018,31(21):128.[doi:10.3969/j.issn.1006-1959.2018.19.038]
[10]吴永惠.缺血性中风病的中医药治疗[J].医学信息,2022,35(12):89.[doi:10.3969/j.issn.1006-1959.2022.12.021]
　WU Yong-hui.Traditional Chinese Medicine Treatment of Ischemic Stroke[J].Journal of Medical Information,2022,35(21):89.[doi:10.3969/j.issn.1006-1959.2022.12.021]

更新日期/Last Update: 1900-01-01